Microhealth
ActiveDigital hematology
This company has previously operated under “MicroHealth”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
What we do? We develop digital therapeutics to address unmet medical needs in hematology and oncology. How it works? First we build networks of doctors and patients designed to track, predict and prevent disease. Second, we validate the safety and efficacy of our interventions in pivotal clinical studies to obtain regulatory clearance (SaMD). Finally, we aim to commercialize our products as prescription digital therapeutics (DTx). Where are we now? Today, we are the standard in digital hematology: * Our hemophilia network covers 33% of all patients and providers in the US. * We bested 20+ competitors, including several Fortune 500 companies. * Our clients include: Sanofi, Bayer, Novo Nordisk, Biogen, and Roche.
Founders · 2
● 10+ years as Digital Health startup CEO ● Deep relationships across the biopharma ecosystem ● 10+ years as Managing Director (healthcare) at global bank ● Y Combinator (YC_S15) alumni
Expert indigital health, including: - Launching products for new therapeutic areas - Improving health outcomes - Clinical and HEOR studies - Domestic and global deployments - Predictive AI for medical and commercial goals
Related startups
Makers of simple, affordable medical devices. Our award-winning…
On-demand prescription delivery.
